Unhydrogenated, unsaturated vegetable oils, such as canola oil, can have health advantages when included in as part of a low-glycemic index (GI) diet in people with type 2 diabetes, according to research presented at American Diabetes Association Scientific Sessions in San Francisco, and published in Diabetes Care.
Unhydrogenated, unsaturated vegetable oils, such as canola oil, can have health advantages when included in as part of a low-glycemic index (GI) diet in people with type 2 diabetes, according to research presented at the American Diabetes Association (ADA) Scientific Sessions in San Francisco, and published in Diabetes Care.
“Use of canola oil enriched whole wheat bread-providing 31 g of Canola oil per day-in a low GI diet improved blood glucose control in type 2 diabetes assessed as HbA1c, and reduced blood lipids, notably LDL-C,” according to lead researcher David J.A. Jenkins, MD, PhD, DSc, professor and Canada research chair in nutrition and metabolism, department of nutritional Sciences, University of Toronto as well as director, Risk Factor Modification Center, St. Michael's Hospital.
In a multicenter, randomized controlled trial, Dr Jenkins and colleagues studied 141 participants with type 2 diabetes who were taking drugs to control blood glucose were randomized to either a low glycemic load diet, emphasizing canola oil (31 g/day), or a diet with a whole wheat emphasis. Participants were followed for 3 months on this parallel design study with body weight, blood pressure, and blood measures made at the beginning and the last month of the study. Results showed that those who consumed the canola oil diet improved blood glucose control. Importantly, participants at increased risk for adverse effects from type 2 diabetes, such as those with high blood pressure, derived the greatest benefits.
“These changes would be expected to reduce the risk of coronary heart disease significantly,” Dr Jenkins said. “Manipulations which reduce coronary heart disease risk are particularly important in diabetes where the risk of cardiovascular disease is double for men and up to 4 times that seen in the non-diabetic population for women.”
“Formulary managers in hospitals and managed care companies may wish to continue the focus on plant foods in the diet and consider including canola oil in their diets not only for cooking purposes but more importantly as the cold oil in salad dressings, on boiled vegetables to increase palatability and on snack foods such as bruschetta in much the same situation as olive oil is used in Mediterranean cuisine,” said Dr Jenkins.
This is the first study to assess the combination of healthy fat consumption and a low-GI diet. The beneficial health effects of canola oil and its fat components (eg, monounsaturated and omega-3 fats) have been independently shown in other studies.
Get the latest industry news, event updates, and more from Managed healthcare Executive.
PBM-Offered Genomics Testing Could Reshape Prescribing of Medications
July 25th 2025Two PBMs, True Rx Health Strategies and Capital Rx, are using pharmacogenomics — how a person’s DNA affects their response to medications — to reduce the trial-and-error of prescribing medications, saving employers and patients time and money.
Read More
Diabetes Management & Telehealth with Leslie Kolb
June 11th 2020Association of Diabetes Care and Education Specialists, chief science and practice officer, Leslie Kolb chats with MHE Associate Editor Briana Contreras in MHE's newest podcast Tuning into the C-Suite about diabetes management and how it's affected by the use of telehealth, especially during the current and trying times of the COVID-19 pandemic.
Listen
FDA Extends Review of Blenrep Combinations in Multiple Myeloma
July 24th 2025Last week, an FDA advisory committee against the risk-benefit profile of Blenrep in combination with other therapies. Regulators and reviewers were concerned about the ocular side effects and dosing and tolerability. The new action date is Oct. 23, 2025.
Read More
Sarepta to Pause Shipments of the Gene Therapy Elevidys
July 22nd 2025Sarepta officials said the temporary halt in shipments was done to maintain a productive working relationship with regulators while they address a safety labeling update about the risk of acute liver disease related to Elevidys.
Read More